According to the latest Global Burden of Disease Study, cardiovascular disease (CVD) is the
leading cause of death, and ischemic heart disease and stroke are the cause of death in …

The incidence and clinical presentation of ischemic heart disease (IHD), as well as
thrombotic and bleeding risks, appear to differ between genders. Compared with men …

Aims In AFFIRM‐AHF, intravenous ferric carboxymaltose (FCM) reduced heart failure (HF)
hospitalisations and improved quality of life versus placebo in iron‐deficient patients …

Background. Myocardial ischemia/reperfusion (MI/R) injury is a common pathology in
ischemia heart disease. Long noncoding RNAs (lncRNAs) are significant regulators related …

Patients with heart failure (HF) have augmented vascular tone, which increases cardiac
workload, impairing ventricular output and promoting further myocardial dysfunction. The …

Abstract Monoamine oxidase A (MAO-A) is a prominent myocardial source of reactive
oxygen species (ROS), and its expression and activity are strongly increased in failing …

Coronary heart disease (CHD) is the leading cause of death around the world. Based on the
roles of vascular endothelial growth factor (VEGF) family members to regulate blood and …

Background Coronary heart disease (CHD) brings a heavy burden to society worldwide.
Novel and minimally invasive biomarkers for the risk evaluation of CHD are urgently …

Although it is known that caffeic acid phenethyl ester (CAPE) and its derivatives could
ameliorate acute myocardial injury, their effects on chronic myocardial ischemia (CMI) were …

Abstract Myocardial Ischemic Injury is a serious threat to human health, and DJ-1 is involved
in cardioprotection. The research intended to explore the effects and mechanism of DJ-1 to …